Selecta Biosciences Inc. (SELB) is priced at $1.84 after the most recent trading session. At the very opening of the session, the stock price was $1.57 and reached a high price of $1.73, prior to closing the session it reached the value of $1.65. The stock touched a low price of $1.57.Recently in News on August 4, 2022, Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update. – Completed enrollment of DISSOLVE II, triggering a $10 million milestone payment obligation from Swedish Orphan Biovitrum AB (publ.) (Sobi); DISSOLVE I & II studies remain on track for joint topline data readout in Q1 2023 –. You can read further details here
Selecta Biosciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.3500 on 01/03/22, with the lowest value was $0.6469 for the same time period, recorded on 05/11/22.
Selecta Biosciences Inc. (SELB) full year performance was -55.41%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Selecta Biosciences Inc. shares are logging -60.85% during the 52-week period from high price, and 184.43% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.65 and $4.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1709558 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Selecta Biosciences Inc. (SELB) recorded performance in the market was -49.39%, having the revenues showcasing 114.17% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 248.95M, as it employees total of 58 workers.
Analysts verdict on Selecta Biosciences Inc. (SELB)
During the last month, 0 analysts gave the Selecta Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.1973, with a change in the price was noted +0.18. In a similar fashion, Selecta Biosciences Inc. posted a movement of +10.61% for the period of last 100 days, recording 1,913,938 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SELB is recording 0.46 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.45.
Selecta Biosciences Inc. (SELB): Technical Analysis
Raw Stochastic average of Selecta Biosciences Inc. in the period of last 50 days is set at 88.17%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 70.19%. In the last 20 days, the company’s Stochastic %K was 54.80% and its Stochastic %D was recorded 48.31%.
Let’s take a glance in the erstwhile performances of Selecta Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -49.39%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -35.55%, alongside a downfall of -55.41% for the period of the last 12 months. The shares increased approximately by 4.43% in the 7-day charts and went down by 22.22% in the period of the last 30 days. Common stock shares were driven by 114.17% during last recorded quarter.